News

NHS launches drive to catch one of the most lethal cancers

Hundreds of GP practices will comb patient records to offer urgent tests to people most at risk of pancreatic cancer, one of the deadliest forms of the disease. GP teams will scour online patients records to identify people over 60 who have the key early warning signs of pancreatic cancer including being recently diagnosed with […]

Read more

Millions to benefit from NHS robot drive

Millions of patients will benefit from cutting-edge NHS robotic surgery over the next decade as part of radical plans to cut waiting times. Half a million operations will be supported by the trailblazing approach every year by 2035, up from 70,000 in 2023/24, according to NHS projections. 9 in 10 of all keyhole surgeries, such […]

Read more

NHS rolls out more personalised cervical screening for millions

More accurate human papillomavirus (HPV) testing will enable millions of women and people with a cervix in England to benefit from more personalised cervical screening from next month, the NHS has announced today. From July, younger women (aged 25 to 49) who test negative for HPV, meaning they are at very low risk of cervical […]

Read more

NHS first in world to roll out ‘revolutionary’ blood test for cancer patients

Tens of thousands of patients with lung and breast cancer are to benefit from a “revolutionary” blood test on the NHS across England which can speed up access to targeted therapy. The new ‘liquid biopsy’ test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid […]

Read more

NHS rolls out 5-minute ‘super-jab’ for 15 cancers

Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection. The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or monthly treatment in 5 […]

Read more

Targeted breast cancer treatment approved for routine NHS use

Women with advanced breast cancer could soon have access to a new targeted treatment on the NHS, following a decision by the National Institute for Health and Care Excellence (NICE). The tablet capivasertib, used alongside fulvestrant, has been approved for patients with hormone receptor-positive, HER2-negative breast cancer that has progressed after earlier endocrine treatment. It […]

Read more